Shelby Livingston

A federal judge has dismissed part of Eli Lilly’s lawsuit alleging Empower Pharmacy misled customers about its compounded versions of the obesity drug tirzepatide.

Health tech correspondent Last year, health insurer after health insurer slashed or withdrew their profit outlooks after being …

UnitedHealth Group’s Optum Rx on Monday unveiled a new approach to prescription drug benefits that it said offers its customers transparency into the entire drug supply chain.

A startup that spun out of UC Berkeley aims to improve healthcare operations by getting AI to think like a doctor would.

Utah has released early data from a closely watched program that tests using AI to renew prescriptions for patients with chronic conditions.

Signos, a startup that aims to help people lose weight by understanding their blood sugar, has raised a new $20 million round of funding as it looks beyond its direct-to-consumer roots to employers, health insurers and pharma companies.

Signos raised $20 million for its approach to using continuous glucose monitors to help people lose weight. And Oura unveiled today its latest, smallest ring.

Ilant Health has raised a $15M Series A funding round to expand its personalized approach to treating obesity.

Last week, Eli Lilly proclaimed that its weight loss shot and pill are now “covered for millions of Americans,” now that all three major pharmacy benefit managers have put the drugs on their commercial formularies. But it’s not that simple.

Elevance is pouring $1B into AI, but its digital chief says the goal is practical—better tools and an empathetic experience, not flashy new use cases.